Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jin-Quan Cai"'
Autor:
Shu-Shang Chen, Mei-Jiao Lin, Ming-Fang Weng, Ling-Feng Zhu, Zhen Deng, Cheng-Yao Wu, Jin-Quan Cai, Wei-Zhen Wu, Jian-Ming Tan
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 34, Iss 10, Pp 576-582 (2018)
To explore the influence of prostate size on the outcome of Plasmakinetic enucleation of the prostate (PkEP) for the treatment of benign prostate hyperplasia (BPH), The data of 892 patients with symptomatic BPH who underwent PkEP were retrospectively
Externí odkaz:
https://doaj.org/article/858a2b154fe34f14a0f2e97db0d924fa
Publikováno v:
Chinese Medical Journal, Vol 129, Iss 4, Pp 464-471 (2016)
Objective: To summary the recent advances in molecular research of glioblastoma (GBM) and current trends in personalized therapy of this disease. Data Sources: Data cited in this review were obtained mainly from PubMed in English up to 2015, with key
Externí odkaz:
https://doaj.org/article/81b8758d1a634042aa4a99db6a2d7451
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
Autor:
Ming-Yang Li, Yin-Yan Wang, Jin-Quan Cai, Chuan-Bao Zhang, Kuan-Yu Wang, Wen Cheng, Yan-Wei Liu, Wei Zhang, Tao Jiang
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0130872 (2015)
Isocitrate dehydrogenase 1 gene mutations are found in most World Health Organization grade II and III gliomas and secondary glioblastomas. Isocitrate dehydrogenase 1 mutations are known to have prognostic value in high-grade gliomas. However, their
Externí odkaz:
https://doaj.org/article/299ff9feee93453f84f6cc14a4275651
Autor:
Chenguang Wu, Kai Zheng, Shun-liang Yang, Jian-ming Tan, Fuqiang He, Wenping Zhu, Jin-quan Cai, Wei-zhen Wu, Zhixian Wu, Xia Gao
Publikováno v:
Transplant Immunology. 33:13-19
This study aimed to investigate the role of the Notch1/Delta-like 4 signaling pathway and its relationship with T helper 17 (Th17) cells in the peripheral transplantation immune of renal transplant recipients.Fifty-two kidney transplant recipients in
Autor:
Lianghu Huang, Jin-quan Cai, Lianming Liao, Zhixian Wu, Jin Chen, Shunliang Yang, Jianming Tan, Junqi Guo
Publikováno v:
Diabetes
OBJECTIVE—The aim of this study was to evaluate the efficiency and safety of simultaneous islet and kidney transplantation in patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemt
Autor:
Weizhen Wu, Dong Wang, Xia Gao, Shunliang Yang, Zhixian Wu, Lianming Liao, Jianming Tan, Qinghua Wang, Jin-quan Cai
Publikováno v:
Pediatric Transplantation. 12:215-218
To explore the long-term outcomes of paediatric kidney transplantation and the effects of renal allograft on growth, education, employment, marriage and procreation. Twenty-seven children with ESRD received the renal allograft from 1985 to 2001. The
Autor:
Zhi-liang Wang, Chuan-bao Zhang, Zheng Wang, Xiang-qi Meng, Xiao-juan Liu, Bo Han, Chun-bin Duan, Jin-quan Cai, Zhong-fei Hao, Ming-hui Chen, Tao Jiang, Yong-li Li, Chuan-lu Jiang, Hong-jun Wang
Publikováno v:
Carcinogenesis; Mar2018, Vol. 39 Issue 3, p389-396, 8p
Publikováno v:
Diabetes technologytherapeutics. 13(5)
Recently a considerable number of promising clinical trials have been designed to perform infusion of stem cells by pancreatic arterial intervention to improve the endocrine function of the pancreas for better diabetes control. It is necessary to inv
Autor:
Jian-ming Tan, Jin-quan Cai, Shun-liang Yang, Wei-zhen Wu, Dong Wang, Wen-hong Lin, Jin-Hua Chen, Ting-zhao Xu
Publikováno v:
Transplant immunology. 20(3)
Second renal transplants are historically associated with a poor prognosis. The aim of the present study was to assess long-term survival of second renal grafts from deceased donors performed at our center and to analyze risk factors associated with
Autor:
Ting-zhao Xu, Jin-quan Cai, Dong Wang, Shun-liang Yang, Jian-ming Tan, Wei-zhen Wu, Wen-hong Lin
Publikováno v:
Transplant immunology. 18(3)
Presensitized renal allograft recipients require special management to improve their outcome, and there is no consensus on the optimal immunosuppressive strategy. We retrospectively analyzed clinical data of 82 patients, who were PRA positive pre-tra